Discovery of CZL-077 as a potent, selective, and orally active p300/CBP bromodomain inhibitor with improved in vivo antitumor efficacy.

inobrodib (CCS1477) - CellCentric

http://www.ncbi.nlm.nih.gov/pubmed/41448045

Haiyan Wan; Hong Yang; Hui Shen; Qiongyu Shi; Ruilin Zhou; Xiaoxue Tan; Xun Huang; Yan Zhang; Ying Zhang; Yingxia Li; Yong Xu; Yujie Wang; Yuxin Yang; Zonglong Chen

Dec 26, 2025